down arrow

Central Pharmaceutical JSC No. 3

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: VN000000DP36
VND
51,000.00
-300 (-0.58%)

Dec 12

HSTC

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
94,243.65
91,902.24
1,16,175.93
95,223.92
1,02,431.17
1,03,654.41
97,995.19
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
94,243.65
91,902.24
1,16,175.93
95,223.92
1,02,431.17
1,03,654.41
97,995.19
Raw Material Cost
32,198.76
31,882.70
40,890.60
34,958.48
35,197.88
33,827.95
33,740.66
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
10,475.20
17,044.12
10,512.34
14,100.69
13,079.18
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
296.06
64.80
0.00
0.00
76.76
84.74
291.74
Selling and Distribution Expenses
29,754.39
31,541.34
19,716.35
33,975.86
37,984.31
43,705.60
8,726.57
Other Expenses
-29.61
-1,054.00
-1,704.41
-1,051.23
-1,417.74
-1,316.39
-29.17
Total Expenditure (Excl Depreciation)
61,953.15
63,424.04
60,606.95
68,934.33
73,182.19
77,533.55
42,467.23
Operating Profit (PBDIT) excl Other Income
32290.5
28478.2
55569
26289.6
29249
26120.9
55528
Other Income
8,921.67
1,588.21
7,116.75
651.15
5,976.81
1,650.08
8,149.94
Operating Profit (PBDIT)
41,116.52
32,472.98
65,546.44
29,456.56
38,358.22
31,164.36
67,162.86
Interest
296.06
64.80
0.00
0.00
76.76
84.74
291.74
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
62,044.89
60,019.53
75,285.33
60,265.45
67,233.29
69,826.47
64,254.53
Depreciation
0.00
2,513.06
2,860.71
2,695.71
3,425.19
3,467.45
3,484.95
Profit Before Tax
40,820.47
29,895.12
62,685.73
26,760.85
34,856.27
27,612.17
63,386.17
Tax
8,721.26
6,030.88
12,593.16
5,456.83
7,123.00
5,570.45
12,848.82
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
32,099.21
23,864.24
50,092.56
21,304.02
27,733.27
22,041.72
50,537.34
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
32,099.21
23,864.24
50,092.56
21,304.02
27,733.27
22,041.72
50,537.34
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
32,099.21
23,864.24
50,092.56
21,304.02
27,733.27
22,041.72
50,537.34
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
10000.0
10000.0
10000.0
10000.0
10000.0
10000.0
10000.0
Reserves
5,10,344.34
5,42,744.93
5,18,880.70
4,68,788.13
4,47,484.11
4,90,513.81
4,68,472.08
Earnings per share (EPS)
1492.99
1109.97
2329.89
990.89
1289.92
1025.2
2350.58
Diluted Earnings per share
1492.99
1109.97
2329.89
990.89
1289.92
1025.2
2350.58
Operating Profit Margin (Excl OI)
34.16%
30.87%
47.83%
27.42%
28.27%
25.13%
56.66%
Gross Profit Margin
43.31%
35.26%
56.42%
30.93%
37.37%
29.98%
68.24%
PAT Margin
34.06%
25.97%
43.12%
22.37%
27.08%
21.26%
51.57%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2025 is 2.55% vs -20.89% in Mar 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2025 is 34.51% vs -52.36% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2025 is 4.24% vs -47.14% in Mar 2025

stock-summary

Interest

QoQ Growth in quarter ended Jun 2025 is 356.94% vs 0.00% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

Compare Quarterly Results Of Central Pharmaceutical JSC No. 3 With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(VND)
Change(%)
Net Sales
94,243.65
7,05,172.64
-6,10,928.99
-86.64%
Other Operating Income
0.00
0.00
0.00
Total Operating income
94,243.65
7,05,172.64
-6,10,928.99
-86.64%
Raw Material Cost
32,198.76
3,63,264.07
-3,31,065.31
-91.14%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
1,21,999.52
-1,21,999.52
-100.00%
Power Cost
0
0
0.00
Manufacturing Expenses
296.06
1,777.91
-1,481.85
-83.35%
Selling and Distribution Expenses
29,754.39
2,58,344.31
-2,28,589.92
-88.48%
Other Expenses
-29.61
-12,377.74
12,348.13
99.76%
Total Expenditure (Excl Depreciation)
61,953.15
6,21,608.38
-5,59,655.23
-90.03%
Operating Profit (PBDIT) excl Other Income
32,290.50
83,564.25
-51,273.75
-61.36%
Other Income
8,921.67
10,655.23
-1,733.56
-16.27%
Operating Profit (PBDIT)
41,116.52
1,17,488.96
-76,372.44
-65.00%
Interest
296.06
1,777.91
-1,481.85
-83.35%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
62,044.89
3,41,908.57
-2,79,863.68
-81.85%
Depreciation
0.00
23,269.48
-23,269.48
-100.00%
Profit Before Tax
40,820.47
92,441.57
-51,621.10
-55.84%
Tax
8,721.26
17,649.19
-8,927.93
-50.59%
Provisions and contingencies
0
0
0.00
Profit After Tax
32,099.21
68,455.90
-36,356.69
-53.11%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
32,099.21
68,455.90
-36,356.69
-53.11%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
5,605.23
-5,605.23
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
32,099.21
74,061.13
-41,961.92
-56.66%
Equity Capital
0
0
0.00
Face Value
10,000.00
10,000.00
0.00
Reserves
5,10,344.34
14,42,301.71
-9,31,957.37
-64.62%
Earnings per share (EPS)
1,492.99
1,651.51
-158.52
-9.60%
Diluted Earnings per share
1,492.99
1,651.51
-158.52
-9.60%
Operating Profit Margin (Excl OI)
34.16%
11.85%
0.00
22.31%
Gross Profit Margin
43.31%
16.41%
0.00
26.90%
PAT Margin
34.06%
9.71%
0.00
24.35%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 9,424.37 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 2.55% vs -20.89% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -7.99% vs 1.51% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 3,209.92 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 34.51% vs -52.36% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 15.74% vs -15.51% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3,219.49 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 4.24% vs -47.14% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -0.58% vs -4.88% in Jun 2024

Quarterly - Interest
Interest 29.61 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 356.94% vs 0.00% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 285.55% vs -82.40% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 34.16%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."